Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses.
Orasis Pharmaceuticals has raised €25M across 1 funding round from 2 investors, most recently a round in Sep 2020. Based in Herzliya, Israel; founded 2015; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-09-10 | Other | €25M |
| Bluestem Capital,Visionary Venture Fund |
| View deal → |
